48.25 USD
-0.85 (-1.73%)
48.25 USD
0 (0%)
Overall SUPN gets a fundamental rating of 5 out of 10. We evaluated SUPN against 190 industry peers in the Pharmaceuticals industry. SUPN has an average financial health and profitability rating. SUPN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- SUPN had positive earnings in the past year.
- SUPN had a positive operating cash flow in the past year.
- SUPN had positive earnings in each of the past 5 years.
- In the past 5 years SUPN always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of SUPN (-1.35%) is better than 75.39% of its industry peers.
- With a decent Return On Equity value of -1.82%, SUPN is doing good in the industry, outperforming 77.49% of the companies in the same industry.
- The Return On Invested Capital of SUPN (2.34%) is better than 79.58% of its industry peers.
- SUPN had an Average Return On Invested Capital over the past 3 years of 2.70%. This is significantly below the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.35% | ||
| ROE | -1.82% | ||
| ROIC | 2.34% |
ROA(3y)3.02%
ROA(5y)4.13%
ROE(3y)4.71%
ROE(5y)7.54%
ROIC(3y)2.7%
ROIC(5y)4.37%
1.3 Margins
- SUPN's Profit Margin has declined in the last couple of years.
- SUPN has a Operating Margin of 6.08%. This is in the better half of the industry: SUPN outperforms 79.58% of its industry peers.
- In the last couple of years the Operating Margin of SUPN has declined.
- With an excellent Gross Margin value of 89.91%, SUPN belongs to the best of the industry, outperforming 92.15% of the companies in the same industry.
- In the last couple of years the Gross Margin of SUPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.08% | ||
| PM (TTM) | N/A | ||
| GM | 89.91% |
OM growth 3Y-9.85%
OM growth 5Y-18.4%
PM growth 3Y6.61%
PM growth 5Y-17.27%
GM growth 3Y0.96%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
- SUPN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, SUPN has more shares outstanding
- SUPN has more shares outstanding than it did 5 years ago.
- SUPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- SUPN has an Altman-Z score of 5.80. This indicates that SUPN is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.80, SUPN is doing good in the industry, outperforming 75.92% of the companies in the same industry.
- SUPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.8 |
ROIC/WACC0.25
WACC9.38%
2.3 Liquidity
- A Current Ratio of 1.80 indicates that SUPN should not have too much problems paying its short term obligations.
- The Current ratio of SUPN (1.80) is worse than 65.97% of its industry peers.
- A Quick Ratio of 1.56 indicates that SUPN should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.56, SUPN is not doing good in the industry: 61.26% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.56 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 0.32% over the past year.
- Measured over the past 5 years, SUPN shows a small growth in Earnings Per Share. The EPS has been growing by 6.93% on average per year.
- The Revenue has been growing slightly by 4.54% in the past year.
- The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)0.32%
EPS 3Y44.39%
EPS 5Y6.93%
EPS Q2Q%-13.68%
Revenue 1Y (TTM)4.54%
Revenue growth 3Y4.51%
Revenue growth 5Y11%
Sales Q2Q%9.34%
3.2 Future
- SUPN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.52% yearly.
- Based on estimates for the next years, SUPN will show a quite strong growth in Revenue. The Revenue will grow by 14.93% on average per year.
EPS Next Y-5.26%
EPS Next 2Y20.17%
EPS Next 3Y17.74%
EPS Next 5Y19.52%
Revenue Next Year9.16%
Revenue Next 2Y16.26%
Revenue Next 3Y16.13%
Revenue Next 5Y14.93%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 15.56, SUPN is valued correctly.
- 86.39% of the companies in the same industry are more expensive than SUPN, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.21. SUPN is valued slightly cheaper when compared to this.
- A Price/Forward Earnings ratio of 11.33 indicates a reasonable valuation of SUPN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SUPN indicates a rather cheap valuation: SUPN is cheaper than 85.86% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 25.98. SUPN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.56 | ||
| Fwd PE | 11.33 |
4.2 Price Multiples
- 80.10% of the companies in the same industry are more expensive than SUPN, based on the Enterprise Value to EBITDA ratio.
- SUPN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SUPN is cheaper than 79.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.1 | ||
| EV/EBITDA | 18.57 |
4.3 Compensation for Growth
- SUPN's earnings are expected to grow with 17.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)2.25
EPS Next 2Y20.17%
EPS Next 3Y17.74%
5. Dividend
5.1 Amount
- SUPN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SUPERNUS PHARMACEUTICALS INC / SUPN FAQ
Can you provide the ChartMill fundamental rating for SUPERNUS PHARMACEUTICALS INC?
ChartMill assigns a fundamental rating of 5 / 10 to SUPN.
What is the valuation status for SUPN stock?
ChartMill assigns a valuation rating of 6 / 10 to SUPERNUS PHARMACEUTICALS INC (SUPN). This can be considered as Fairly Valued.
What is the profitability of SUPN stock?
SUPERNUS PHARMACEUTICALS INC (SUPN) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for SUPN stock?
The Earnings per Share (EPS) of SUPERNUS PHARMACEUTICALS INC (SUPN) is expected to decline by -5.26% in the next year.